dalteparin and coumarin

dalteparin has been researched along with coumarin in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's2 (22.22)18.2507
2000's4 (44.44)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
del Rio, L; Lafoz, E; Monreal, M; Olive, A; Vedia, C1
Agundez, I; Arreba, E; Carrera, S; Castrodeza, J; Fernandez, L; Gonzalez-Fajardo, JA; Gutiérrez, V; Mateo, AM; Perez, JL; Vaquero, C1
Alhenc-Gelas, M; Corazza, F; Demulder, A; Ferster, A; Loop, M1
HOLYOKE, JB; WHEELWRIGHT, HJ1
Baker, RI; Bowden, C; Gent, M; Julian, JA; Kakkar, AK; Lee, AY; Levine, MN; Prins, M; Rickles, FR1
Cho, CH; Choi, SY; Keum, DY; Kwon, KY; Lee, JH; Park, NH1
Castrodeza, J; González-Fajardo, JA; Martin-Pedrosa, M; Tamames, S; Vaquero-Puerta, C1
Bereczky, Z; Boda, Z; Olah, Z; Szarvas, M1
Abreu, P; Carrier, M; Feugère, G; Heissler, J; Lee, AYY; Woodruff, S1

Trials

6 trial(s) available for dalteparin and coumarin

ArticleYear
Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
    Thrombosis and haemostasis, 1994, Volume: 71, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Contraindications; Coumarins; Dalteparin; Female; Fractures, Spontaneous; Hemorrhage; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Patient Compliance; Pulmonary Embolism; Recurrence; Spinal Fractures; Thromboembolism

1994
Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
    Journal of vascular surgery, 1999, Volume: 30, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Coumarins; Enoxaparin; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Phlebography; Thrombophlebitis; Time Factors

1999
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-01, Volume: 23, Issue:10

    Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Coumarins; Dalteparin; Female; Heparin, Low-Molecular-Weight; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Survival Analysis; Thromboembolism; Treatment Outcome

2005
Low molecular weight heparin treatment in pregnant women with a mechanical heart valve prosthesis.
    Journal of Korean medical science, 2007, Volume: 22, Issue:2

    Topics: Adult; Coumarins; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hydrocephalus; Nadroparin; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Thrombosis; Treatment Outcome

2007
Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
    Journal of vascular surgery, 2008, Volume: 48, Issue:4

    Topics: Anticoagulants; Coumarins; Enoxaparin; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Postthrombotic Syndrome; Prospective Studies; Recurrence; Thromboembolism; Time Factors; Venous Thrombosis

2008
Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study.
    Journal of thrombosis and thrombolysis, 2019, Volume: 47, Issue:4

    Topics: Aged; Coumarins; Dalteparin; Disease-Free Survival; Female; Hemorrhage; Humans; Male; Middle Aged; Neoplasms; Survival Rate; Thrombosis; Venous Thromboembolism

2019

Other Studies

3 other study(ies) available for dalteparin and coumarin

ArticleYear
Late onset of clinical symptoms and recurrent ecchymotic skin lesions in a 12-year-old girl with a severe double heterozygous protein C deficiency.
    Journal of pediatric hematology/oncology, 2004, Volume: 26, Issue:1

    Topics: Age of Onset; Anticoagulants; Child; Coumarins; DNA Mutational Analysis; Ecchymosis; Family Health; Female; Heterozygote; Humans; Mutation, Missense; Nadroparin; Necrosis; Protein C Deficiency; Recurrence; Skin Diseases

2004
The effect of depo-heparin on the prothrombin time, with observations on the combined use of heparin and dicumarol.
    The New England journal of medicine, 1952, Jan-03, Volume: 246, Issue:1

    Topics: Coumarins; Dalteparin; Dicumarol; Hemostatics; Heparin; Humans; Prothrombin; Prothrombin Time

1952
Coagulation: cascade!
    Lancet (London, England), 2011, Aug-20, Volume: 378, Issue:9792

    Topics: Aged; Anticoagulants; Coumarins; Enoxaparin; Gangrene; Heparin; Humans; International Normalized Ratio; Male; Necrosis; Thrombocytopenia; Venous Thrombosis

2011